Over the last 7 days, the Pharma industry has risen 3.3%, driven by gains from Bora Pharmaceuticals of 12%. In the last 12 months, the industry was up 6.3%. Looking forward, earnings are forecast to grow by 40% annually.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 26 May 2024 | NT$622.7b | NT$100.4b | NT$7.1b | 32.4x | 87.1x | 6.2x |
Tue, 23 Apr 2024 | NT$605.4b | NT$101.8b | NT$9.4b | 24.6x | 64.7x | 5.9x |
Thu, 21 Mar 2024 | NT$624.1b | NT$100.9b | NT$9.4b | 25.4x | 66.2x | 6.2x |
Sat, 17 Feb 2024 | NT$609.4b | NT$101.6b | NT$8.2b | 24x | 74.7x | 6x |
Mon, 15 Jan 2024 | NT$575.6b | NT$101.9b | NT$7.8b | 24.2x | 73.9x | 5.7x |
Wed, 13 Dec 2023 | NT$576.3b | NT$101.6b | NT$7.6b | 24x | 75.6x | 5.7x |
Fri, 10 Nov 2023 | NT$569.7b | NT$101.8b | NT$9.6b | 22.2x | 59.1x | 5.6x |
Sun, 08 Oct 2023 | NT$548.3b | NT$101.7b | NT$9.6b | 21.6x | 57x | 5.4x |
Tue, 05 Sep 2023 | NT$561.1b | NT$101.7b | NT$9.6b | 22.7x | 58.3x | 5.5x |
Thu, 03 Aug 2023 | NT$571.8b | NT$98.7b | NT$10.1b | 16.8x | 56.8x | 5.8x |
Sat, 01 Jul 2023 | NT$609.6b | NT$98.7b | NT$10.1b | 17.4x | 60.6x | 6.2x |
Mon, 29 May 2023 | NT$575.1b | NT$97.9b | NT$11.0b | 18.3x | 52.3x | 5.9x |
Wed, 26 Apr 2023 | NT$556.9b | NT$92.1b | NT$8.6b | 22.1x | 64.4x | 6x |
Fri, 24 Mar 2023 | NT$546.2b | NT$90.2b | NT$7.8b | 19.8x | 69.9x | 6.1x |
Sun, 19 Feb 2023 | NT$554.2b | NT$84.6b | NT$7.9b | 24.7x | 70.3x | 6.5x |
Tue, 17 Jan 2023 | NT$482.8b | NT$84.6b | NT$7.9b | 20.6x | 61.2x | 5.7x |
Thu, 15 Dec 2022 | NT$501.4b | NT$84.6b | NT$7.9b | 21.5x | 63.6x | 5.9x |
Sat, 12 Nov 2022 | NT$427.6b | NT$80.0b | NT$4.7b | 16.9x | 91.3x | 5.3x |
Mon, 10 Oct 2022 | NT$439.6b | NT$78.9b | NT$4.3b | 17.4x | 101.6x | 5.6x |
Wed, 07 Sep 2022 | NT$455.6b | NT$78.9b | NT$4.3b | 18.4x | 105.3x | 5.8x |
Fri, 05 Aug 2022 | NT$372.4b | NT$76.8b | NT$4.5b | 21x | 83.2x | 4.8x |
Sun, 03 Jul 2022 | NT$381.0b | NT$76.8b | NT$4.4b | 20.9x | 87.2x | 5x |
Tue, 31 May 2022 | NT$380.2b | NT$76.8b | NT$4.4b | 20.1x | 87x | 5x |
Thu, 28 Apr 2022 | NT$390.2b | NT$76.5b | NT$6.5b | 21.1x | 59.8x | 5.1x |
Sat, 26 Mar 2022 | NT$403.9b | NT$76.6b | NT$8.9b | 20.5x | 45.2x | 5.3x |
Mon, 21 Feb 2022 | NT$404.2b | NT$76.7b | NT$8.5b | 19.3x | 47.7x | 5.3x |
Wed, 19 Jan 2022 | NT$373.5b | NT$76.7b | NT$8.5b | 18.8x | 44.1x | 4.9x |
Fri, 17 Dec 2021 | NT$392.4b | NT$76.7b | NT$8.5b | 18.3x | 46.4x | 5.1x |
Sun, 14 Nov 2021 | NT$364.5b | NT$76.3b | NT$8.0b | 16.4x | 45.7x | 4.8x |
Tue, 12 Oct 2021 | NT$348.0b | NT$76.0b | NT$10.7b | 18.9x | 32.4x | 4.6x |
Thu, 09 Sep 2021 | NT$355.7b | NT$76.0b | NT$10.7b | 19.2x | 33.1x | 4.7x |
Sat, 07 Aug 2021 | NT$368.8b | NT$76.0b | NT$10.7b | 21.3x | 34.4x | 4.9x |
28.3x
How does Taiwanese Pharma compare with similar industries?
TW Market | 1.41% | |
Healthcare | -1.12% | |
Pharma | -1.96% | |
Pharma | -1.96% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6919 Caliway Biopharmaceuticals | NT$413.00 | 9.5% +NT$5.0b | 142.2% | PS1469x | |
1752 Nang Kuang Pharmaceutical | NT$55.40 | 18.4% +NT$868.5m | -15.0% | PE35.2x | |
4127 Tien Liang BioTech | NT$45.35 | 12.1% +NT$224.2m | 196.4% | PE110.4x | |
4111 Chi Sheng Pharma & Biotech | NT$29.85 | 12.6% +NT$190.9m | 3.3% | PE23.3x | |
4166 Orient Pharma | NT$27.55 | 1.8% +NT$111.5m | 27.5% | PE275.7x |